RadNet Inc. logo

RadNet Inc. (RDNT)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
62. 19
-0.8
-1.27%
$
4.94B Market Cap
930.4 P/E Ratio
- Div Yield
820,900 Volume
0.55 Eps
$ 62.99
Previous Close
Add Transaction
Day Range
58.97 63.01
Year Range
50.76 85.84
Want to track RDNT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RDNT closed yesterday lower at $62.19, a decrease of -1.27% from Thursday's close, completing a monthly increase of 13.6098% or $7.45. Over the past 12 months, RDNT stock lost -12.7892%.
RDNT is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0.1533%. On average, the company has fell short of earnings expectations by -0.0889%, based on the last three reports.
RadNet Inc. has completed 1 stock splits, with the recent split occurring on Nov 28, 2006.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

RDNT Chart

People also search for

Voya U.S. Stock Index Portfolio
$ 13.61
-1.0182%
LGN
Legence Corp.
$ 68.24
-1.2874%
Churchill Capital Corp XI Warrant
$ 7
+2.6393%
Blue Bird Corporation
$ 78.34
+0.8496%
Payoneer Global Inc.
$ 7.12
+0.4231%
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools

RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools

RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.

Zacks | 2 weeks ago
Do Options Traders Know Something About RadNet Stock We Don't?

Do Options Traders Know Something About RadNet Stock We Don't?

Investors need to pay close attention to RDNT stock based on the movements in the options market lately.

Zacks | 1 month ago
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript

RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript

RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago

RadNet Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
100 $6,094.41 $6,296.04 $201.63 3.31%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
619 $43,655.47 $39,015.57 -$4,639.9 -10.63%
George Soros
George Soros Soros Fund Management LLC
438,450 $31.49M $27.6M -$3.89M -12.34%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
105,191 $7.04M $6.62M -$421,158.54 -5.98%
BG
Bart Gancher Intech Investment Management LLC
30,053 $1.65M $1.9M $245,268.66 14.84%

RadNet Inc. (RDNT) FAQ

What is the stock price today?

The current price is $62.19.

On which exchange is it traded?

RadNet Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is RDNT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.94B.

Has RadNet Inc. ever had a stock split?

RadNet Inc. had 1 splits and the recent split was on Nov 28, 2006.

RadNet Inc. Profile

Professional Services Industry
Industrials Sector
Howard G. Berger CEO
NASDAQ (NMS) Exchange
750491102 CUSIP
US Country
11,000 Employees
- Last Dividend
28 Nov 2006 Last Split
1 Jul 1986 IPO Date

Overview

RadNet, Inc., established in 1981 and headquartered in Los Angeles, California, establishes a prominent position in the United States healthcare infrastructure by providing comprehensive outpatient diagnostic imaging services. The company differentiates its offerings by structuring its operations into two primary segments: Imaging Centers and Artificial Intelligence. This dual-focused approach allows RadNet to cater to the diverse needs of healthcare providers and patients, ensuring both traditional and technologically advanced diagnostic solutions. Through its extensive network and innovative technology deployment, RadNet sets itself apart as a key contributor to the evolving landscape of diagnostic imaging services.

Products and Services

RadNet, Inc. offers a broad spectrum of diagnostic imaging and related services, alongside advanced AI technologies for image interpretation and screening. Below is an elaborated list of its products and services:

  • Magnetic Resonance Imaging (MRI): This service provides detailed images of organs and tissues within the body, utilizing magnetic fields and radio waves. MRI is pivotal for diagnosing a range of conditions, from brain disorders to musculoskeletal injuries.
  • Computed Tomography (CT): CT scans offer cross-sectional images of the body through the use of X-rays and computing algorithms. They are essential in detecting various diseases and conditions, including cancers, heart disease, and internal injuries.
  • Positron Emission Tomography (PET): PET scans, often used in conjunction with CT or MRI scans, provide metabolic and physiological data by detecting radioactive materials injected into the body. This is crucial for cancer diagnosis and monitoring, as well as neurological and cardiac applications.
  • Nuclear Medicine: This involves the use of small amounts of radioactive material to diagnose or treat diseases, including many types of cancers, heart disease, and other abnormalities within the body.
  • Mammography: Specializing in the early detection of breast cancer, mammography utilizes low-dose X-rays to examine breast tissue. This is a critical tool in breast cancer screening and diagnostics.
  • Ultrasound: Using sound waves to produce images of structures within the body, ultrasound services are essential for monitoring pregnancies, diagnosing pelvic and abdominal conditions, and guiding minimally invasive procedures.
  • Diagnostic Radiology: This encompasses a range of imaging modalities, including X-ray, fluoroscopy, and more, to diagnose diseases and conditions across the body.
  • Fluoroscopy: Providing real-time images of the movement of internal fluids, organs, or devices, fluoroscopy is vital for guiding various diagnostic and therapeutic procedures.
  • Multi-Modality Imaging Services: RadNet offers comprehensive imaging solutions that combine multiple diagnostic techniques to provide a holistic view of a patient’s health condition.
  • Computerized Systems for Image Distribution: The company develops advanced systems for the efficient distribution, display, storage, and retrieval of digital images, enhancing the flow of diagnostic information.
  • Picture Archiving Communications Systems (PACS) and Related Services: These systems and services are key to the management of digital imaging and electronic records, improving accessibility and efficiency in healthcare settings.
  • Artificial Intelligence Suites: RadNet develops and deploys AI technologies aimed at enhancing the interpretation of images related to breast, lung, and prostate, alongside providing AI solutions for prostate cancer screening. This technological advancement represents RadNet’s commitment to integrating cutting-edge technology within diagnostic practices.

Contact Information

Address: 1508, 1510 and 1516 Cotner Avenue
Phone: 310 478 7808